Increase your confidence in the purity and safety test results in biotherapeutic manufacturing workflows. When safety is paramount and ensuring regulatory compliance is non-negotiable, genetic analysis of product functionality and purity based on sequencing and fragment analysis can help to mitigate risk and accelerate lot disposition.
Expand opportunities for advancements in quality control with genetic studies on microbial and residual vector impurities and unintended cell line proliferation.
Explore changing frequencies of genetic variants in your cultured and stored cells and tissues to identify potential genes associated with resistance to your biopharmaceutical.
Track and characterize changing frequencies in biomarkers associated with responses to your biopharmaceutical.
A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.
Discover QualTrak qPCR and dPCR workflows for mAbs, vaccines, and cell and gene therapies across biopharmaceutical development and manufacturing.
Efficiently develop and characterize recombinant monoclonal antibodies (mAbs) from discovery through clinical trials and manufacturing by incorporating genetic-level analysis into your workflows.
We support you with exceptional services, remote tools, training, and OEM expertise we’ve spent 40 years curating.
Download flyer ›